We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,325 hedge funds and large institutions have $47B invested in Edwards Lifesciences in 2026 Q2 according to their latest regulatory filings, with 164 funds opening new positions, 464 increasing their positions, 466 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 6 → 10 (+4)

61% more first-time investments, than exits

New positions opened: 164 | Existing positions closed: 102

16% more capital invested

Capital invested by funds: $40.3B → $47B (+$6.65B)

3.05% more ownership

Funds ownership: 87.38% → 90.42% (+3%)

3% more funds holding

Funds holding: 1,288 → 1,325 (+37)

0% less repeat investments, than reductions

Existing positions increased: 464 | Existing positions reduced: 466

6% less call options, than puts

Call options by funds: $168M | Put options by funds: $180M

Holders
1,325
Holders Change
+37
Holders Change %
+2.87%
% of All Funds
16%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.12%
New
164
Increased
464
Reduced
466
Closed
102
Calls
$168M
Puts
$180M
Net Calls
-$11.4M
Net Calls Change
+$65.2M

Top Buyers

Rank Fund Capital Flow
1
Aristotle Capital Management
Aristotle Capital Management
California
+$726M
2
BlackRock
BlackRock
New York
+$519M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$435M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$317M
5
Citadel Advisors
Citadel Advisors
Florida
+$291M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$1.07B
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$508M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$434M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$222M
5
Marshall Wace
Marshall Wace
United Kingdom
-$138M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$362M +$291M +3,478,894 +670%
Invesco
27
Invesco
Georgia
$360M -$70.2M -837,832 -17%
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$335M +$5.48M +65,418 +2%
Charles Schwab
29
Charles Schwab
California
$334M +$11.4M +135,946 +4%
Millennium Management
30
Millennium Management
New York
$324M +$150M +1,787,974 +100%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$317M +$88.3M +1,054,448 +43%
Primecap Management
32
Primecap Management
California
$308M -$1.21M -14,500 -0.4%
Vanguard Fiduciary Trust
33
Vanguard Fiduciary Trust
Pennsylvania
$292M -$2.76M -32,990 -1%
Holocene Advisors
34
Holocene Advisors
New York
$284M +$201M +2,401,186 +325%
Nuveen
35
Nuveen
North Carolina
$268M +$5.63M +67,224 +2%
Neuberger Berman Group
36
Neuberger Berman Group
New York
$261M +$45M +536,774 +23%
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$259M -$103M -1,233,360 -30%
Jacobs Levy Equity Management
38
Jacobs Levy Equity Management
New Jersey
$251M -$13.5M -160,564 -5%
NAMI
39
Nomura Asset Management International
Pennsylvania
$238M -$11.3M -134,941 -5%
Amundi
40
Amundi
France
$233M -$7.58M -90,461 -3%
MU
41
Mirova US
Massachusetts
$230M -$7.28M -86,934 -3%
Allspring Global Investments
42
Allspring Global Investments
North Carolina
$229M +$35.9M +428,505 +21%
Raymond James Financial
43
Raymond James Financial
Florida
$220M +$17M +202,870 +9%
UBS Group
44
UBS Group
Switzerland
$213M -$17.7M -211,120 -8%
Russell Investments Group
45
Russell Investments Group
United Kingdom
$207M +$11.1M +132,947 +6%
BNP Paribas Asset Management
46
BNP Paribas Asset Management
France
$176M -$13.6M -162,545 -8%
SEI Investments
47
SEI Investments
Pennsylvania
$172M +$55.4M +661,136 +53%
Assenagon Asset Management
48
Assenagon Asset Management
Luxembourg
$164M +$45.8M +547,212 +43%
Point72 Asset Management
49
Point72 Asset Management
Connecticut
$160M -$4.39M -52,417 -3%
Allianz Asset Management
50
Allianz Asset Management
Germany
$157M -$644K -7,686 -0.4%
1
2
3 4 5

EW Hedge Fund Activity: Q2 2026 in Review

1,325 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2026, worth a combined $47B — up 16% from $40.3B a quarter earlier.

Buyers outnumbered sellers: 164 funds opened new EW positions and 102 closed out — a net gain of 62 holders — while 464 added to existing stakes and 466 trimmed.

The largest buyer was Aristotle Capital Management, opening a new position worth an estimated $726M. The largest seller was Jennison Associates, cutting an estimated $1.07B.

  • 1,325 institutional investors held Edwards Lifesciences (EW) as of Q2 2026, up from 1,288 in Q1 2026.
  • Funds reported $47B of Edwards Lifesciences stock for Q2 2026, up 16% quarter-over-quarter.
  • 164 funds opened new Edwards Lifesciences positions in Q2 2026 and 102 closed out, a net change of +62 holders.
  • The largest Edwards Lifesciences buyer in Q2 2026 was Aristotle Capital Management, an estimated $726M added.
  • The largest Edwards Lifesciences seller in Q2 2026 was Jennison Associates, an estimated $1.07B sold.

Based on aggregated 13F filings for Q2 2026.